Clinical trial
Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic…
NCT00002643 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00002643 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor |
| Official title | INTENSIVE THERAPY WITH GROWTH FACTOR SUPPORT FOR PATIENTS WITH EWING'S TUMOR METASTATIC AT DIAGNOSIS: A PEDIATRIC ONCOLOGY GROUP PHASE II STUDY |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Children's Cancer Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neutropenia, Sarcoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, amifostine trihydrate, cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, topotecan hydrochloride, vincristine sulfate, conventional surgery, low-LET cobalt-60 gamma ray therapy and 2 more |
| Enrollment | 130 |
| Start date | Apr 1, 1995 |
| Primary completion | Jun 1, 2003 |
| First posted | Jun 18, 2003 |
| Last update posted | Feb 1, 2013 |
| Countries | Australia, Canada, Puerto Rico, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: